Quince Therapeutics, Inc. (QNCX)
1.07
-0.01
(-0.93%)
USD |
NASDAQ |
May 21, 16:00
1.06
-0.01
(-0.93%)
After-Hours: 19:59
Quince Therapeutics Research and Development Expense (TTM) : 34.08M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | 382.53M |
| BioXcel Therapeutics, Inc. | 27.94M |
| Gossamer Bio, Inc. | 179.10M |
| Ernexa Therapeutics, Inc. | 4.762M |
| Acurx Pharmaceuticals, Inc. | 1.577M |